Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
24.9% overvalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
24
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.8% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
5.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.9% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
MediWound
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
EscharEx Trials And Aging Populations Will Expand Wound Markets
Key Takeaways Strategic partnerships and regulatory tailwinds position MediWound to potentially dominate its market, with rapid adoption expected post-approval and significant upside to revenue outlooks. Government contracts and strong global demand are poised to drive long-term growth, boost margins, and open robust new channels for non-dilutive revenues.
View narrative
US$39.00
FV
55.4% undervalued
intrinsic discount
28.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Southland Holdings
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
IIJA Funding And Urbanization Will Drive Modern Civil Megaprojects
Key Takeaways Rapid conversion of high-margin backlog and legacy project completion are set to drive faster, more sustained earnings acceleration and margin expansion. Specialized capabilities, geographic dominance, and advanced construction methods position Southland to outperform peers as public investment and project complexity rise.
View narrative
US$8.00
FV
47.8% undervalued
intrinsic discount
9.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Inventiva
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Global Aging Trends Will Spark Demand For MASH Treatments
Key Takeaways Leadership in multimodal metabolic therapies and innovative clinical positioning could drive outsized revenue and expand Inventiva's market reach over time. Decisive restructuring and strategic partnerships enhance margins and acquisition appeal, positioning the company for industry-leading financial performance and transformative growth opportunities.
View narrative
€10.00
FV
61.2% undervalued
intrinsic discount
185.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
a.k.a. Brands Holding
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Omnichannel And Mobile Commerce Will Expand Retail Horizons
Key Takeaways Omnichannel expansion, social channel investments, and supply chain agility position the company for sustained growth, higher margins, and increased market share in fast fashion. Strong cash generation and operational efficiencies enable reinvestment, potential M&A, and shareholder returns, underpinning a structurally higher long-term valuation.
View narrative
US$30.00
FV
64.2% undervalued
intrinsic discount
4.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
FuelCell Energy
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Electrification And Green Hydrogen Will Power Clean Grids
Key Takeaways Aggressive cost reductions and restructuring could significantly boost profitability and earnings ahead of expectations, supporting improved margins and accelerated financial performance. Strategic partnerships, scalable technology, and recurring revenue models position the company to benefit from surging demand for reliable, low-carbon energy in the data center and grid markets.
View narrative
US$12.00
FV
66.8% undervalued
intrinsic discount
37.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
E.W. Scripps
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
CTV And Political Ads Will Drive Media Transformation Despite Risks
Key Takeaways Scripps is positioned to lead industry consolidation post-deregulation, rapidly expand scale, and unlock significant efficiency and cash flow advantages over rivals. Strong financial discipline, digital ad leadership, and dominant political ad exposure set Scripps up for superior earnings, margin, and market share growth.
View narrative
US$10.00
FV
68.6% undervalued
intrinsic discount
-2.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
PSQH
PSQ Holdings
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Values Driven Fintech Will Thrive As Crypto Meets AI
Key Takeaways Aggressive cost controls and rapid tech adoption are driving sustainable profitability, giving PSQ a structural advantage over peers in efficiency and margins. Strong fintech positioning and values-based growth fuel robust user engagement, network effects, and outsized revenue potential within emerging digital and crypto ecosystems.
View narrative
US$8.00
FV
79.0% undervalued
intrinsic discount
58.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
TerrAscend
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
US Cannabis Legalization And Digital Health Will Unlock Opportunities
Key Takeaways Expansion into new states, operational efficiencies, and premium branding position TerrAscend for strong revenue growth and improved margins versus industry peers. Strategic M&A, digital platform expansion, and disciplined cost control create potential for sustainable earnings growth and increased market share as the sector consolidates.
View narrative
CA$2.25
FV
38.7% undervalued
intrinsic discount
0.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Hansa Biopharma
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Accelerated Immunotherapy Adoption Will Fuel Global Market Expansion
Key Takeaways Accelerating market adoption, strategic partnerships, and regulatory momentum are positioning IDEFIRIX and imlifidase for stronger revenue and profit growth than currently expected. Cost-cutting measures and executive restructuring enhance operational savings, supporting margin expansion regardless of sales fluctuations, while novel therapies open up new, underappreciated revenue streams.
View narrative
SEK 143.00
FV
76.8% undervalued
intrinsic discount
124.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies